Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Chiron Corporation

Information provided by (Responsible Party):

H. Lee Moffitt Cancer Center and Research Institute

ClinicalTrials.gov Identifier:

NCT00100906

First received: January 6, 2005

Last updated: February 12, 2013

Last verified: February 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2013
Primary Completion Date:	June 2006 (Final data collection date for primary outcome measure)

Publications: